FDA Inspection 554235 — Innovative Chemical Corporation

Innovative Chemical Corporation — FEI 3005329497

The FDA completed an inspection of Innovative Chemical Corporation on Jan 27, 2009 in Cottage Grove, MN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 16 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 27, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Cottage Grove, MN (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
117721 CFR 211.63Equipment Design, Size and Location
122721 CFR 211.67(c)Cleaning/maintenance records not kept
136121 CFR 211.100(a)Absence of Written Procedures
139521 CFR 211.103Actual vs. theoretical yields not determined
150521 CFR 211.122(d)Label storage access limited to authorized personnel
154021 CFR 211.125(a)Strict control not exercised over labeling issued
179121 CFR 211.80(c)Storage off Floor, Spaced Suitably
189021 CFR 211.165(e)Test methods
191421 CFR 211.166(a)Lack of written stability program
200721 CFR 211.186(a)Signature and checking of records -- 2 persons
241921 CFR 211.198(a)Complaint Handling Procedure
431421 CFR 211.84(d)(2)Reports of Analysis (Components)
436921 CFR 211.188(b)(11)Identification of persons involved, each significant step
437221 CFR 211.188(b)(8)Labeling control records including specimens or copies
900121 CFR 211.22(a)Lack of quality control unit